Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q84058686)
Watch
English
Bladder cancer
scientific article published on 10 June 2009
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Bladder cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
author name string
Donald S Kaufman
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
William U Shipley
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
Adam S Feldman
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
language of work or name
English
0 references
publication date
10 June 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
volume
374
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
page(s)
239-249
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
issue
9685
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
cites work
p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Loss of p63 expression is associated with tumor progression in bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ras signal transduction in carcinogenesis and progression of bladder cancer: molecular target for treatment?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetic alterations in urothelial bladder carcinoma: an updated review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inactivation of the FHIT gene favors bladder cancer development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Arsenic cancer risk confounder in southwest Taiwan data set
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history and treatment of low and high risk superficial bladder tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BTA stat and BTA TRAK: A comparative evaluation of urine testing for the diagnosis of transitional cell carcinoma of the bladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Detection of bladder cancer using a point-of-care proteomic assay
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Urine markers for bladder cancer surveillance: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The value of a second transurethral resection in evaluating patients with bladder tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The value of a second transurethral resection for T1 bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Routine excretory urography in follow-up of superficial transitional cell carcinoma of bladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Factors affecting recurrence and progression in superficial bladder tumours.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Superficial bladder cancer: progression and recurrence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary ca
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcome of radical cystectomy for bladder cancer according to the disease type at presentation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Outcome after radical cystectomy with limited or extended pelvic lymph node dissection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Urinary diversion: options, patient selection, and outcomes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Continent urinary reconstruction versus ileal conduit: a contemporary single-institution comparison of perioperative morbidity and mortality
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates--the Massachusetts General Hospital and Radiation Therapy Oncology Group experiences
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemoth
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overview of bladder cancer trials in the European Organization for Research and Treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of muscle invasive bladder cancer--British approaches to organ conservation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant chemotherapy for bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Surgery and adjunctive chemotherapy for invasive bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Current understanding of the biology of advanced bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Docetaxel and cisplatin in metastatic urothelial cancer: a phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
What we could do now: molecular pathology of bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EGFR, HER2 and VEGF pathways: validated targets for cancer treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeted therapies in bladder cancer--an update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Positive response to bevacizumab in a patient with metastatic, chemotherapy-refractory urothelial carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960491-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(09)60491-8
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
PubMed ID
19520422
1 reference
stated in
Europe PubMed Central
PubMed ID
19520422
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19520422%20AND%20SRC:MED&resulttype=core&format=json
retrieved
31 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit